Vtv Therapeutics(VTVT.US)盘前涨31%报2.33美元。公司公布疗牛皮癣的口服PDE4抑制剂HPP737的多次递增剂量研究和开发计划结果称,HPP737表现出良好的安全性和耐受性,没有剂量限制的胃肠道副作用。结果支持HPP737在中度至重度牛皮癣中进入... 网页链接
$vTv Therapeutics(VTVT)$ 8-K Current report, item 1.01 Accession Number: 0001641489-24-000054 Act: 34 Size: 145 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-078626 Size: 27 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641489-24-000047 Size: 7 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641489-24-000051 Size: 5 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641489-24-000049 Size: 5 KB 网页链接
$vTv Therapeutics(VTVT)$ 8-K Current report, item 5.07 Accession Number: 0001641489-24-000045 Act: 34 Size: 166 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016730 Size: 5 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641489-24-000038 Size: 5 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641489-24-000039 Size: 5 KB 网页链接
$vTv Therapeutics(VTVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001641489-24-000040 Size: 5 KB 网页链接